In vitro sensitivity to 5-FU and gemcitabine in pancreatic cancer. Background: Patients with biliary tract cancer (BTC) have a high risk of developing cholangitis. In patients with advanced BTC ...
DelveInsight’s 'Primary Sclerosing Cholangitis (PSC) Pipeline Insight 2022' report provides comprehensive global coverage of available, marketed, and pipeline Primary Sclerosing Cholangitis therapies ...
Effective treatments for patients with primary biliary cholangitis are limited. Seladelpar, a peroxisome proliferator–activated receptor delta agonist, has potential benefits. In this phase 3, ...
Primary biliary cholangitis is a rare, chronic cholestatic liver disease characterized by the destruction of interlobular bile ducts, leading to cholestasis and liver fibrosis. Whether elafibranor, an ...
Health on MSN
What To Know About Primary Biliary Cholangitis (PBC)
Medically reviewed by Jay N. Yepuri, MD PBC is a chronic liver disease that damages bile ducts and can lead to liver failure. You can get treatment for PBC to slow disease progression and manage ...
Ipsen’s elafibranor has shown promise as a treatment for primary sclerosing cholangitis (PSC), a rare liver disease that currently has no approved treatment options. Results from the phase 2 ELMWOOD ...
The survey of European hepatologists demonstrates the lack of clarity in guidelines. A new survey of European health care centers with expertise in managing primary sclerosing cholangitis (PSC) ...
Journal of Zoo and Wildlife Medicine, Vol. 45, No. 1 (March 2014), pp. 143-147 (5 pages) An adult male Amur tiger (Panthera tigris altaica) with confirmed inflammatory bowel disease developed acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback